[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.161.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,939
Citations 0
Editorial
April 26, 2016

New Horizons in Allergen Immunotherapy

Author Affiliations
  • 1Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA. 2016;315(16):1711-1712. doi:10.1001/jama.2016.4078

Even though allergen immunotherapy has been studied for more than a century, a great deal remains unknown about this commonly used treatment.1 Immunotherapy, which is of benefit to the majority of appropriately selected patients, still largely relies on the injection of relatively crude allergen extracts, often involving doses that have not been rigorously studied.2 The renewed interest in the study of immunotherapy over the past decade is encouraging and has resulted in important advances, including development of more refined allergens, assessment of different routes of delivery, and studies on the treatment of food allergy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×